| 2026-06-16 | Mr. Anthony K. K. NgaiIndependent Director | 500,00 | 6,25k | Kauf | 12,50 | 97,91k | 0,51% |
| 2026-06-11 | Ms. Katherine S. Ngai-PesicChairman of the Board | -200,00k | 2,25M | Verkauf | 11,27 | 12,76M | -1,54% |
| 2026-06-05 | Mr. Anthony K. K. NgaiIndependent Director | 1.000,00 | 13,07k | Kauf | 13,07 | 97,41k | 1,04% |
| 2026-06-03 | Mr. Iliya I. PesicDirector | -6,00k | 77,73k | Verkauf | 12,96 | 5,38M | -0,11% |
| 2026-05-14 | Ms. Candace JacksonSenior VP, General Counsel & Corporate Secretary | -2,00k | 22,00k | Verkauf | 11,00 | 51,35k | -3,75% |
| 2026-04-01 | Ms. Candace JacksonSenior VP, General Counsel & Corporate Secretary | -1,82k | 12,94k | Verkauf | 7,12 | 53,35k | -3,29% |
| 2026-04-01 | Mr. Christopher J. ZegarelliCFO | -2,43k | 17,28k | Verkauf | 7,11 | 27,31k | -8,17% |
| 2025-11-17 | Mr. Iliya I. PesicDirector | -400,00k | 772,80k | Verkauf | 1,93 - 1,94 | 5,35M | -6,96% |
| 2025-06-26 | Ms. Katherine S. Ngai-PesicChairman of the Board | -950,00k | 2,02M | Verkauf | 2,00 - 2,26 | 12,93M | -6,84% |
| 2025-12-04 | Ms. Katherine S. Ngai-PesicChairman of the Board | -300,00k | 597,00k | Verkauf | 1,99 | 3,60M | -7,69% |
| 2026-03-17 | Ms. Candace JacksonSenior VP, General Counsel & Corporate Secretary | -1,50k | 7,51k | Verkauf | 5,00 | 2,65k | -36,11% |
| 2026-01-01 | Ms. Candace JacksonSenior VP, General Counsel & Corporate Secretary | -1,40k | 5,68k | Sale to Issuer | 4,05 | 2,01k | -41,06% |
| 2025-12-11 | Mr. Anthony K. K. NgaiIndependent Director | 1.000,00 | 4,23k | Kauf | 4,23 | 60,53k | 1,68% |
| 2025-12-10 | Ms. Katherine S. Ngai-PesicChairman of the Board | 25,00k | 103,31k | Kauf | 4,13 | 14,18M | 0,18% |
| 2025-12-09 | Dr. Walden C. RhinesCEO & Director | 13,10k | 52,50k | Kauf | 4,01 | 74,67k | 21,28% |
| 2025-12-09 | Ms. Katherine S. Ngai-PesicChairman of the Board | -170,00k | 0,00 | Other Disposition | - | 14,16M | -1,19% |
| 2025-12-08 | Mr. Christopher J. ZegarelliCFO | 10,00k | 37,95k | Kauf | 3,80 | 23,49k | 74,11% |
| 2025-11-18 | Mr. Anthony K. K. NgaiIndependent Director | 10,00k | 42,56k | Kauf | 4,26 | 59,53k | 20,19% |
| 2025-11-19 | Ms. Candace JacksonSenior VP, General Counsel & Corporate Secretary | -8,30k | 35,28k | Verkauf | 4,25 | 12,00 | -99,86% |
| 2025-11-18 | Dr. Walden C. RhinesCEO & Director | 29,00k | 118,17k | Kauf | 4,07 | 61,57k | 89,04% |
| 2025-11-17 | Mr. Christopher J. ZegarelliCFO | 5,00k | 19,55k | Kauf | 3,91 | 13,49k | 58,87% |
| 2025-11-17 | Dr. Walden C. RhinesCEO & Director | 11,27k | 43,98k | Kauf | 3,90 | 32,57k | 52,93% |
| 2025-09-15 | Mr. Christopher J. ZegarelliCFO | 5,10k | 25,65k | Kauf | 5,03 | 8,49k | 150,31% |
| 2025-10-01 | Ms. Candace JacksonSenior VP, General Counsel & Corporate Secretary | -2,51k | 13,65k | Sale to Issuer | 5,44 | 8,31k | -23,19% |
| 2025-09-08 | Mr. Anthony K. K. NgaiIndependent Director | 11,70k | 61,79k | Kauf | 5,16 - 5,34 | 49,53k | 30,93% |
| 2025-08-13 | Dr. Babak Alizadeh TaheriInsider | -9,16k | 42,57k | Sale to Issuer | 4,65 | 773,16k | -1,17% |